FILE PHOTO: Vials of Pfizer's coronavirus disease vaccine are seen at a pop-up community vaccination center at the Gateway World Christian Center in Valley Stream, New York, U.S., February 23, 2021. REUTERS/Brendan McDermid/File PhotoBioNTech SE could have capacity to make 3 billion doses of the COVID-19 vaccine it developed with partner Pfizer next year, Bloomberg News reported on Tuesday , citing an interview with the German company's chief executive officer.
While BioNTech could increase manufacturing capacity in principle, it depends on demand and factors such as requirement of additional boost to vaccinations, CEO Ugur Sahin told Bloomberg News.Pfizer last month said it aims to make at least 2 billion doses of its COVID-19 vaccine in 2021.
Singapore Latest News, Singapore Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.